VIA Pharmaceuticals

About:

VIA Pharmaceuticals is a biotechnology company focused on the development of small-molecule drugs to treat cardiovascular diseases.

Website: http://www.viapharmaceuticals.com

Top Investors: Bay City Capital

Description:

VIA Pharmaceuticals is a biotechnology company focused on the treatment of cardiovascular disease.VIA is building a pipeline of small-molecule drugs that target a significant unmet medical need – reducing inflammation in the blood vessel wall, which is an underlying cause of atherosclerosis and its complications, including heart attack and stroke.

Total Funding Amount:

$13.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2004-01-01

Founders:

Oye Olukotun

Number of Employees:

1-10

Last Funding Date:

2010-11-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai